53
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Coating with spermine-pullulan polymer enhances adenoviral transduction of mesenchymal stem cells

, , , , , , , , & show all
Pages 6763-6769 | Published online: 13 Dec 2016

References

  • WangSQuXZhaoRClinical applications of mesenchymal stem cellsJ Hematol Oncol201251922546280
  • MendicinoMBaileyAMWonnacottKPuriRKBauerSRMSC-based product characterization for clinical trials: an FDA perspectiveCell Stem Cell201414214114524506881
  • CaplanAIAdult mesenchymal stem cells: when, where, and howStem Cells Int2015201562876726273305
  • MizuguchiHHayakawaTTargeted adenovirus vectorsHum Gene Ther200415111034104415610604
  • YaoXLNakagawaSGaoJQCurrent targeting strategies for adenovirus vectors in cancer gene therapyCurr cancer drug targets201111781082521762081
  • RoelvinkPWLizonovaALeeJGThe coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and FJ Virol19987210790979159733828
  • Knaan-ShanzerSvan de WateringMJvan der VeldeIGoncalvesMAValerioDde VriesAAEndowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cellsStem Cells200523101598160716293583
  • JanssenJMLiuJSkokanJGoncalvesMAde VriesAADevelopment of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cellsJ Gene Med201315111123225636
  • YaoXYoshiokaYMorishigeTAdenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administrationBiol Pharm Bull20103361073107620522982
  • YaoXYoshiokaYMorishigeTTumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapyMol Ther20111991619162521673661
  • YaoX-LYoshiokaYRuanG-XOptimization and internalization mechanisms of pegylated adenovirus vector with targeting peptide for cancer gene therapyBiomacromolecules20121382402240922746837
  • YaoXZhouNWanLPolyethyleneimine-coating enhances adenoviral transduction of mesenchymal stem cellsBiochem Biophys Res Commun2014447338338724727452
  • KasmanLBaruaSLuPRegeKVoelkel-JohnsonCPolymer-enhanced adenoviral transduction of CAR-negative bladder cancer cellsMol Pharm2009651612161919655763
  • HanJZhaoDZhongZZhangZGongTSunXCombination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transductionNanotechnology2010211010510620154380
  • SingarapuKPalIRamseyJDPolyethylene glycol-grafted polyethylenimine used to enhance adenovirus gene deliveryJ Biomed Mater Res A201310171857186423712991
  • OkazakiAJoJTabataYA reverse transfection technology to genetically engineer adult stem cellsTissue Eng200713224525117518561
  • HeCXLiNHuYLEffective gene delivery to mesenchymal stem cells based on the reverse transfection and three-dimensional cell culture systemPharm Res20112871577159021347566
  • ZhangTYHuangBYuanZYHuYLTabataYGaoJQGene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfectionNanomedicine201410125726723770065
  • ZhangTYHuangBWuHBSynergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in miceJ Control Release201520926027125966361
  • HuYLMiaoPHHuangBReversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticlesJ Biomed Nanotechnol201410229930824738338
  • EtoYYoshiokaYMukaiYOkadaNNakagawaSDevelopment of PEGylated adenovirus vector with targeting ligandInt J Pharm20083541–23817904316
  • YaoXYoshiokaYMorishigeTSystemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasisGene Ther200916121395140419641532
  • MizuguchiHKayMAEfficient construction of a recombinant adenovirus vector by an improved in vitro ligation methodHum Gene Ther1998917257725839853524
  • MizuguchiHKayMAA simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectorsHum Gene Ther199910122013201710466635
  • GaoJQEtoYYoshiokaYEffective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administrationJ Control Release2007122110211017628160
  • MaizelJVJrWhiteDOScharffMDThe polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12Virology19683611151255669982
  • JoJIkaiTOkazakiAExpression profile of plasmid DNA obtained using spermine derivatives of pullulan with different molecular weightsJ Biomater Sci Polym Ed200718788389917688746
  • ImelliNMeierOBouckeKHemmiSGreberUFCholesterol is required for endocytosis and endosomal escape of adenovirus type 2J Virol20047863089309814990728
  • ConnerSDSchmidSLRegulated portals of entry into the cellNature20034226927374412621426
  • ChenQShouPZhengCFate decision of mesenchymal stem cells: adipocytes or osteoblasts?Cell Death Differ20162371128113926868907
  • HotamisligilGSJohnsonRSDistelRJEllisRPapaioannouVESpiegelmanBMUncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding proteinScience19962745291137713798910278
  • MenssenAHauplTSittingerMDelormeBCharbordPRingeJDifferential gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenic developmentBMC Genomics20111246121943323